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Abstract. In medical imaging, organ/pathology segmentation models trained on
current publicly available and fully-annotated datasets usually do not well-represent
the heterogeneous modalities, phases, pathologies, and clinical scenarios encoun-
tered in real environments. On the other hand, there are tremendous amounts
of unlabelled patient imaging scans stored by many modern clinical centers. In
this work, we present a novel segmentation strategy, co-heterogenous and adap-
tive segmentation (CHASe), which only requires a small labeled cohort of single
phase imaging data to adapt to any unlabeled cohort of heterogenous multi-phase
data with possibly new clinical scenarios and pathologies. To do this, we pro-
pose a versatile framework that fuses appearance-based semi-supervision, mask-
based adversarial domain adaptation, and pseudo-labeling. We also introduce co-
heterogeneous training, which is a novel integration of co-training and hetero-
modality learning. We have evaluated CHASe using a clinically comprehensive
and challenging dataset of multi-phase computed tomography (CT) imaging stud-
ies (1147 patients and 4577 3D volumes). Compared to previous state-of-the-art
baselines, CHASe can further improve pathological liver mask Dice-Sørensen
coefficients by ranges of 4.2% ∼ 9.4%, depending on the phase combinations:
e.g., from 84.6% to 94.0% on non-contrast CTs.
Keywords: multi-phase segmentation, semi-supervised learning, co-training, do-
main adaptation, liver and lesion segmentation
1 Introduction
Segmenting or delineating anatomical structures is an important task within medical
imaging, e.g., to generate biomarkers, quantify or track disease progression, or to plan
radiation therapy. Manual delineation is prohibitively expensive, which has led to a
considerable body of work on automatic segmentation. However, a perennial problem
in medical imaging is that models trained on available image/mask pairs, e.g., pub-
licly available data, do not always reflect clinical conditions upon deployment, e.g.,
different pathologies, patient characteristics, scanners and imaging protocols. This can
lead to potentially drastic performance gaps. When multi-phase imagery is present,
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e.g., dynamic-contrast computed tomography (CT), these challenges are further com-
pounded, as datasets may differ in their composition of available modalities or each may
even themselves consist of heterogeneous combinations of modalities. The challenges
then are in both managing new patient/disease variations and in harmonizing hetero-
geneous multi-phase data. Ideally segmentation models can be deployed without first
annotating large swathes of additional data matching deployment scenarios. This is our
goal, where we introduce co-heterogenous and adaptive segmentation (CHASe), which
can adapt models trained on single-modal and public data to produce state-of-the-art
results on multi-phase and multi-source clinical data with no extra annotation cost.
Fig. 1. Ground truth and predictions are rendered in green and red, respectively. Despite per-
forming excellently on labeled source data, state-of-the-art fully-supervised models [25] can
struggle on cohorts of multi-phase data with novel conditions, e.g., the patient shown here with
splenomegaly and a TACE-treated tumor. CHASe can adapt such models to perform on new data
without extra annotation.
Our motivation stems from challenges in segmenting from the wildly variable data
found in picture archiving and communication systems (PACSs), which closely follows
deployment scenarios. Without loss of generality, we focus on the important task of
segmenting pathological livers from dynamic CT scans. Liver disease and liver cancer
are major morbidities worldwide, driving efforts toward better detection and character-
ization methods. Dynamic contrast CT is a protocol whereby a patient is imaged under
multiple time-points after a contrast agent is injected. The resulting complementary in-
formation is critical for characterizing liver lesions [30]. Because accurate segmentation
produces important volumetric biomarkers [12,3], there is a rich body of work on auto-
matic segmentation [28,20,49,25,47,23,41,10,36], particularly for CT. Despite this, all
publicly available data [3,18,11,38,7] is limited to venous-phase (single-channel) CTs.
Moreover, when lesions are present, they are typically limited to hepatocellular carci-
noma (HCC) or metastasized tumors, lacking representation of intrahepatic cholangio-
cellular carcinoma (ICC) or the large bevy of benign lesion types. Additionally, public
data may not represent other important scenarios, e.g.,the transarterial chemoemboliza-
tion (TACE) of lesions or splenomegaly, which produce highly distinct imaging pat-
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terns. As Figure 1 illustrates, even impressive leading entries [25] within the public
LiTS challenge [3], can struggle on clinical PACS data, particularly when applied to
non-venous contrast phases.
To meet this challenge, we integrate together powerful, but complementary, strate-
gies: hetero-modality learning, appearance-based consistency constraints, mask-based
adversarial domain adaptation (ADA), and pseudo-labeling. The result is a semi-supervised
model trained on smaller-scale supervised public venous-phase data [3,18,38,11,7] and
large-scale unsupervised multi-phase data. Crucially, we articulate non-obvious inno-
vations that avoid serious problems from a naive integration. A key component is co-
training [4], but unlike recent deep approaches [45,50], we do not need artificial views,
instead treating each phase as a view. We show how co-training can be adopted with a
minimal increase of parameters. Second, since CT studies from clinical datasets may
exhibit any combination of phases, ideally liver segmentation should also be able to ac-
cept whatever combination is available, with performance maximizing as more phases
are available. To accomplish this, we fuse hetero-modality learning [15] together with
co-training, calling this co-heterogeneous training. Apart from creating a natural hetero-
phase model, this has the added advantage of combinatorially exploding the number of
views for co-training from 4 to 15, boosting even single-phase performance. To com-
plement these appearance-based semi-supervision strategies, we also apply pixel-wise
ADA [40], guiding the network to predict masks that follow a proper shape distribution.
Importantly, we show how ADA can be applied to co-heterogeneous training with no
extra computational cost over adapting a single phase. Finally, we address edge cases
using a principled pseudo-labelling technique specific to pathological organ segmenta-
tion. These innovations combine to produce a powerful approach we call CHASe.
We apply CHASe to a challenging unlabelled dataset of 1147 dynamic-contrast CT
studies of patients, all with liver lesions. The dataset, extracted directly from a hospi-
tal PACS, exhibits many features not seen in public single-phase data and consists of
a heterogeneous mixture of non-contrast (NC), arterial (A), venous (V), and delay (D)
phase CTs. With a test set of 100 studies, this is the largest, and arguably the most
challenging, evaluation of multi-phase pathological liver segmentation to date. Com-
pared to strong fully-supervised baselines [25,14] only trained on public data, CHASe
can dramatically boost segmentation performance on non-venous phases, e.g., moving
the mean Dice-Sørensen coefficient (DSC) from 84.5 to 94.0 on NC CTs. Importantly,
performance is also boosted on V phases, i.e., from 90.7 mean DSC to 94.9. Inputting
all available phases to CHASe maximizes performance, matching desired behavior. Im-
portantly, CHASe also significantly improves robustness, operating with much greater
reliability and without deleterious outliers. Since CHASe is general-purpose, it can be
applied to other datasets or even other organs with ease.
2 Related Work
Liver and liver lesion segmentation. In the past decade, several works proposed tradi-
tional machine learning approaches for liver and lesion segmentation using texture and
statistical features [23,41,10]. With the advent of deep learning, fully convolutional net-
works (FCNs) have quickly become dominant. These include 2D [36,2], 2.5D [13,43],
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3D [28,20,49,46], and hybrid [25,47] FCN-like architectures. Some reported results
show that 3D models can improve over 2D ones, but these improvements are some-
times marginal [20]. Whether the benefits justify the much greater complexity must be
assessed on a case-by-case basis.
Like related works, we also use FCNs. However, all prior works are trained and eval-
uated on venous-phase CTs in a fully-supervised manner. In contrast, we aim to robustly
segment a large cohort of multi-phase contrast CT PACS data in a semi-supervised
manner. As such, our work is orthogonal to much of the state-of-the-art, and can, in
principle, incorporate any future fully-supervised solution as a starting point.
Semi-Supervised Learning. Annotating volumetric data is time consuming, spurring
research on semi-supervised segmentation for medical imaging [39]. In co-training,
predictions of different “views” of the same unlabelled data instance are enforced to
be consistent [4], with recent works applying co-training to deep-learning [31,45,50].
Out of these, CHASe is most similar to Qiao et al. [31], but by using different contrast
phases as views, we have no need for artificial view creation [31,45,50]. More im-
portantly, CHASe effects a stronger appearance-based semi-supervision by fusing co-
training with hetero-modality learning (co-heterogenous learning). In addition, CHASe
complements this appearance-based strategy via prediction-based ADA, resulting in
significantly increased performance.
Adversarial domain adaptation (ADA) for semantic segmentation has also received
recent attention in medical imaging [39]. The main idea is to align the distribution
of predictions or features between the source and target domains. There are various
successful methods [40,42,9,6]. Like Tsai et al., we align the distribution of predic-
tions [40], aligning the mask shapes of source and targets. But unlike Tsai et al., we use
ADA in conjunction with appearance-based semi-supervision. In doing so, we show
how ADA can effectively adapt 15 different hetero-phase predictions at the same com-
putational cost over a single-view variant. Moreover, we demonstrate the need for com-
plementary semi-supervised strategies in order to create a robust and practical medical
segmentation system.
In self-learning, a network is first trained with labelled data. The trained model
then produces pseudo labels for the unlabelled data, which is then added to the la-
belled dataset via some scheme [24]. Within medical imaging, this approach has seen
success [48,1,29], although these approaches must guard against the “confirmation
bias” [26] of compounding initial misclassifications [39]. Instead, we introduce co-
heterogenous training and efficiently fuse it with ADA to drive our semi-supervision.
However, as we show later, co-training can also be cast as self-learning with consensus-
based pseudo-labels. Finally, like more standard self-learning, we also generate pseudo-
labels to finetune our model. But, these are designed to deduce and correct likely mis-
takes, so they do not follow the regular “confirmation”-based self-learning framework.
Hetero-Modality Learning. In medical image acquisition, it is common to have mul-
tiple phases or modalities with complementary information, e.g., dynamic CT phases.
In clinical data it is also common to encounter hetero-modality data, i.e., data with
possible missing modalities [15]. Ideally a segmentation model can ingest whatever
phases/modalities are present in the study, with performance improving as more phases
are available. Havaei et al. first introduced hetero-modal fusion for fully-supervised
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Fig. 2. Overview of CHASe. As shown at the top, labelled data, V-phase in our experiments, are
trained using standard segmentation losses while multi-phase unlabelled data are inputted into an
efficient co-heterogenous training pipeline, that minimizes divergence between mask predictions
across all 15 phase combinations. ADA and specialized pseudo-labelling are also applied. Not
shown are the deeply-supervised intermediate outputs of the PHNN backbone.
FCNs [15]. We also incorporate hetero-modal learning, but by fusing it with co-training
we use multi-modal learning as a means to perform appearance-based learning from
unlabelled data. Additionally, co-heterogeneous training combinatorially explodes the
number of views for co-training, significantly boosting even single-phase performance
by augmenting the training data. To the best of our knowledge, we are the first to pro-
pose co-heterogenous training.
3 Method
Although CHASe is not specific to any organ, we will assume the liver for this work
and that we are given a curated and labelled dataset of CTs and masks, e.g., from pub-
lic data sources. We denote this dataset D` = {Xi, Yi}N`i=1, with Xi denoting the set
of available phases and Yi(k) ∈ {0, 1, 2} indicating background, liver, and lesion for
all pixel/voxel indices k. Here, without loss of generality, we assume the CTs are all
V-phase, i.e., Xi = Vi ∀Xi ∈ D`. We also assume we are given a large cohort of unla-
belled multi-phase CTs from a challenging and uncurated clinical source, e.g., a PACS.
We denote this dataset Du = {Xi}Nui=1, where Xi = {NC i, Ai, Vi, Di} for instances
with all contrast phases. When appropriate, we drop the i for simplicity. Our goal is
to learn a segmentation model which can accept any combination of phases from the
target domain and robustly delineate liver or liver lesions, despite possible differences
in morbidities, patient characteristics, and contrast phases between the two datasets.
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Figure 7 overviews the CHASe approach, which integrates supervised learning, co-
heterogenous training, ADA, and specialized pseudo-labelling. We first start by training
a standard fully-supervised segmentation model using the labelled data. Then under
CHASe, we finetune the model using consistency and ADA losses:
L = Lseg + Lcons + λadvLadv, (1)
where L, Lseg , Lcons, Ladv are the overall, supervised, co-heterogenous, and ADA
losses, respectively. To set up adversarial optimization, a discriminator loss, Ld, is also
deployed in competition with (1). We elaborate on each of the above losses in the fol-
lowing subsections. Throughout, we try to minimize hyper-parameters by employing
standard architectures and little loss-balancing.
3.1 Backbone
CHASe relies on an FCN backbone, f(.), for its functionality and can accommodate
any leading FCN network, including the popular U-Net [32] or V-Net [28] style en-
coder/decoders. For this work we instead adopt the deeply-supervised progressive holis-
tically nested network (PHNN) framework [14], which has demonstrated leading seg-
mentation performance for many anatomical structures [14,34,5,22,21], sometimes even
outperforming U-Net [22,21]. Importantly, PHNN has roughly half the parameters and
activation maps of an equivalent encoder/decoder. Since we aim to include additional
components for semi-supervised learning, this lightweightedness is a crucial factor.
Figure 3 depicts the structure of PHNN. In brief, PHNN relies on deep supervision
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Fig. 3. PHNN architecture. Here we use coloring from Figure 7 corresponding to a V-phase
pathway. At each stage of activation, predictions are created and a loss calculated. Similar to
residual-style connections [16], each stage’s predictions are built off the prior one’s using addi-
tion.
in lieu of a decoder and assumes the FCN can be broken into stages based on pooling
layers. With no loss of generality, we assume there are five FCN stages, which matches
popular FCN configurations. PHNN produces a sequence of logits, a(m), using 1 × 1
convolutions and upsamplings operating on the terminal backbone activations of each
Title Suppressed Due to Excessive Length 7
stage. Sharing similarities to residual connections [16], predictions are generated for
each stage using a progressive scheme that adds to the previous stage’s activations:
Yˆ (1) = σ(a(1)), (2)
Yˆ (m) = σ(a(m) + a(m−1)) ∀m > 1, (3)
where σ(.) denotes the softmax operator and Yˆ (.) represents the predictions, with the
final stage’s predictions acting as the actual segmentation output, Yˆ . Being deeply su-
pervised, PHNN optimizes a segmentation loss at each stage:
`seg(f(V ), Y ) =
5∑
j=0
m
5
`ce
(
Yˆ m, Y
)
, (4)
where here we use `ce(., .), which is a cross-entropy loss weighted via prevalence, and
we also weight later stages higher. Prior to any semi-supervised learning, this backbone
is pre-trained using D`:
Lseg = 1
N`
∑
V,Y ∈D`
`seg (f(V ), Y ) . (5)
3.2 Co-Training
With a fully-supervised backbone trained using D`, the task is now to leverage the
cohort of unlabelled dynamic CT data, Du. We employ the ubiquitous semi-supervised
strategy of enforcing consistency. Because dynamic CT consists of the four NC, A, V,
and D phases, each of which is matched to same mask, Y , each phase can be regarded
as a different view of the same data. This provides for a natural co-training objective [4]
of penalizing inconsistencies across mask predictions from different phases.
To do this, we must create predictions for each phase. As Figure 7 illustrates, we
accomplish this by using phase-specific FCN stages, i.e., the first two low-level stages,
and then use a shared set of weights for the later semantic stages. Because convolutional
weights are greater in number in later stages, this allows for a highly efficient multi-
phase setup. All layer weights are initialized using the corresponding fully-supervised
V-phase weights from Sec. 3.1, including the phase-specific layers. Note that activations
across phases remain distinct. Despite the distinct activations, for convenience we abuse
notation and use Yˆ = f(X ) to denote the generation of all phase predictions for one
data instance. When all four phases are available in X , then Yˆ corresponds to {Yˆ NC ,
Yˆ A, Yˆ V , Yˆ D}.
Like Qiao et al. [31] we use the Jensen-Shannon divergence (JSD)[27] to penalize
inconsistencies. However, because it will be useful later we devise the JSD by first
devising a consensus prediction:
M =
1
|Yˆ|
∑
Yˆ ∈Yˆ
Yˆ . (6)
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With a consensus prediction in-hand, the JSD can be expressed as the divergence be-
tween it and each prediction:
`cons(f(X )) = 1|Yˆ|
∑
Yˆ ∈Yˆ
∑
k∈Ω
KL(Yˆ (k) ‖M(k)), (7)
Lcons = 1
Nu
∑
X∈Du
`cons(f(X )), (8)
where Ω denotes the spatial domain and KL(. ‖ .) corresponds to the Kullback-Leibler
divergence taken across the prediction classes. Cast in this way, co-training can be re-
garded as a form of self-learning, where the pseudo-labels correspond to the consensus
prediction in (6). When using the deeply-supervised PHNN, we only calculate the JSD
across the final prediction.
3.3 Co-Heterogeneous Training
While minimizing the loss in (8) can effectively leverage multiple phases of the un-
labelled data, it is not completely satisfactory. Namely, each phase must still be in-
putted separately into the network, and there is no guarantee of a consistent output.
Despite only having single-phase labelled data, ideally, the network should be adapted
for multi-phase operation on Du, meaning it should be able to consume whatever con-
trast phases are available and output a unified prediction that is stronger as more phases
are available.
To do this, we use hetero-modality image segmentation (HeMIS)-style feature fu-
sion [15], which can predict masks given any arbitrary combination of input phases, or
contrast phases in our case. To do this, a set of phase-specific layers produce a set of
phase-specific activations, A, whose cardinality depends on the number of inputs. The
activations are then fused together using first- and second- order statistics, which are
flexible enough to handle any number of inputs:
afuse = concat(µ(A), var(A)), (9)
where afuse denotes the fused feature, and the mean and variance are taken across the
available phases. When only one phase is available, the variance features are set to 0. To
fuse intermediate predictions, an additional necessity for deeply-supervised networks,
we simply take their mean.
For choosing a fusion point, the choice of co-training setup of Sec. 3.2, with its
phase-specific layers, already offers a natural fusion location. We can then readily com-
bine hetero-phase learning with co-training, re-defining a “view” to mean any possible
combination of the four contrast phases. This has the added benefit of combinatorially
exploding the number of co-training views. More formally, we use X ∗ = P(X ) \ {∅}
to denote all possible contrast-phase combinations, where P(.) is the powerset opera-
tor. The corresponding predictions we denote as Yˆ∗. When a data instance has all four
phases, then the cardinality of X ∗ and Yˆ∗ is 15, which is a drastic increase in views.
With hetero-modality fusion in place, the consensus prediction and co-training loss of
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(6) and (7), respectively, can be supplanted by ones that use Yˆ∗:
M =
1
|Yˆ∗|
∑
Yˆ ∈Yˆ∗
Yˆ , (10)
`cons(f(X )) = 1|Yˆ∗|
∑
Yˆ ∈Yˆ∗
∑
k∈Ω
KL(Yˆ (k) ‖M(k)). (11)
When only single-phase combinations are used, (10) and (11) reduce to standard co-
training. To the best of our knowledge we are the first to combine co-training with
hetero-modal learning. This combined workflow is graphically depicted in Figure 7.
3.4 Adversarial Domain Adaptation
The co-heterogeneous training of Sec. 3.3 is highly effective. Yet, it relies on accurate
consensus predictions, which may struggle to handle significant appearance variations
in Du that are not represented in D`. ADA offers an alternative and complementary
approach, provided it is used to train a network to output predictions that follow a pre-
diction distribution learned from labelled data [40]. Since liver shapes between Du and
D` should follow similar distributions, this provides an effective learning strategy that
is not as confounded by differences in appearance. Following Tsai et al. [40], we can
train a discriminator to classify whether a softmax output originates from a labelled- or
unlabelled-dataset prediction. However, because we have a combinatorial number (15)
of possible input phase combinations, i.e., Xˆ ∗, naively domain-adapting all correspond-
ing predictions is prohibitively expensive. Fortunately, the formulations of (7) and (11)
offer an effective and efficient solution. Namely, we can train the discriminator on the
consensus prediction, M . This adapts the combinatorial number of possible predictions
at the same computational cost as performing ADA on only a single prediction.
More formally, let d(.) be defined as an FCN discriminator, then the discriminator
loss can be expressed as
Ld = 1
N`
∑
D`
`ce(d(Yˆ
V ),1) +
1
Nu
∑
Du
`ce(d(M,0)), (12)
where `ce represents a pixel-wise cross-entropy loss. The opposing labels pushes the
discriminator to differentiate semi-supervised consensus predictions from fully-supervised
variants. Unlike natural image ADA [40], we do not wish to naively train the discrim-
inator on all output classes, as it not reasonable to expect similar distributions of liver
lesion shapes across datasets. Instead we train the discriminator on the liver region,
i.e., the union of healthy liver and lesion tissue predictions. Finally, when minimizing
(12), we only optimize the discriminator weights. The segmentation network can now
be tasked with fooling the discriminator, through the addition of an adversarial loss:
Ladv = 1
Nu
∑
Du
`ce(d(M,1)), (13)
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where the ground-truth labels for `ce have been flipped from (12). Note that here we
use single-level ADA as we found the multi-level variant [40] failed to offer significant
enough improvements to offset the added complexity. When minimizing (13), or (1) for
that matter, the discriminator weights are frozen. We empirically set λadv to 0.001.
3.5 Pseudo-Labelling
With an effective integration of co-heterogeneous training and ADA, CHASe can ro-
bustly segment challenging multi-phase unlabelled data. However, as Figure 4 demon-
strates, some scenarios still present challenging edge cases, e.g., lesions treated with
Fig. 4. Hole-Based Pseudo-Labelling. 3D holes greater than 100 voxels are extracted as lesion
pseudo-masks missed by the prediction. Regions outside the hole are ignored. The bottom left
shows a TACE-treated lesion, which is not seen in public datasets.
TACE. To manage these edge cases, we use a simple, but effective, domain-specific
pseudo-labelling.
First, after convergence of (1), we produce predictions on Du using all available
phases and extract any resulting 3D holes in the liver region greater than 100 voxels.
Since there should never be 3D holes, these are mistakes. Under the assumption that
healthy tissue in both datasets should equally represented, we treat these holes as miss-
ing “lesion” predictions. We can then create a pseudo-label, Yh, that indicates lesion at
the hole, with all others regions being ignored. This produces a new “holes” dataset,
Dh = {X , Yh}Nhi=1, using image sets extracted from Du. We then finetune the model
using (1), but replace the segmentation loss of (5) by
Lseg = 1
N`
∑
V,Y ∈D`
`seg(f(V ), Y )
+
λh
Nh
∑
X ,Yh∈Dh
∑
X∈X∗
`seg(f(X), Yh), (14)
where we empirically set λh to 0.01 for all experiments. We found results were not
sensitive to this value. While the hole-based pseudo-labels do not capture all errors,
they only have to capture enough of missing appearances to guide CHASe’s training to
better handle recalcitrant edge cases.
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4 Results
Datasets. To execute CHASe, we require datasets of single-phase labelled and multi-
phase unlabelled studies, Du and D`, respectively. The goal is to robustly segment pa-
tient studies from Du while only having training mask labels from the less representa-
tive D` dataset. 1) For Du, we collected 1147 multi-phase dynamic CT studies (4577
volumes in total) directly from the PACS of Anonymized. The only selection criteria
were patients with biopsied or resected liver lesions, with dynamic contrast CTs taken
within one month before the procedure. Patients may have ICC, HCC, benign or metas-
tasized tumors, along with co-occuring maladies, such as liver fibrosis, splenomegaly,
or TACE-treated tumors. Thus, Du directly reflects the variability found in clinical sce-
narios. We used the DEEDS algorithm [19] to correct any misalignments. 2) ForD`, we
collected 235 V -phase CT studies collected from as many public sources as we could
locate [3,18,11,7]. This is a superset of the LiTS training data [3], and consists of a
mixture of healthy and pathological livers, with only HCC and metastasis represented.
Evaluation Protocols. 1) To evaluate performance on Du, 47 and 100 studies were
randomly selected for validation and testing, with 90 test studies having all four phases.
Given the extreme care required for lesion annotation, e.g., the four readers used in the
LiTS dataset [3], only the liver region, i.e., union of healthy liver and lesion tissue, of
the Du evaluation sets was annotated by a clinician. For each patient study, this was
performed independently for each phase, with a final mask generated via majority vot-
ing. 2) We also evaluate whether the CHASe strategy of learning from unlabelled data
can also improve performance on D`. To do this, we split D`, with 70%/10%/20% for
training, validation, and testing, respectively, resulting in 47 test volumes. To measure
CHASe’s impact on lesion segmentation, we use the D` test set.
Backbone Network. We opted for a 2D segmentation backbone, an effective choice
for many organs [14,25,33,35], due to its simplicity and efficiency. We opt for the pop-
ular ResNet-50 [17]-based DeepLabv2 [8] network with PHNN-style deep supervision.
We also experimented with VGG-16 [37], which also performed well, and its results
can be found in the supplementary material. To create 3D masks we simply stack the
2D predictions.
CHASe training. We randomly sample multi-phase volume slices and, from them,
randomly sample four view combinations from X ∗ to stochastically minimize (11) and
(13). For standard co-training baselines, we sample all available phases to minimize (7).
Discriminator Network. We use an atrous spatial pyramid pooling (ASPP) layer,
employing dilation rates of 1,2,3,4 with a kernel size of 3 and a leaky ReLU with neg-
ative slope 0.2 as our activation function. After a 1 × 1 convolution, a sigmoid layer
classifies whether a pixel belongs to the labelled or unlabelled dataset.
Specific details on data pre-processing, learning rates and schedules can be found
in the supplementary material.
4.1 Pathological Liver Segmentation
We first measure the performance of CHASe on segmenting pathological livers from the
unlabeled Anonymized PACS dataset, i.e., Du. We use PHNN trained only on D` as a
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baseline, testing against different unlabeled learning baselines, i.e., co-training [4], co-
heterogeneous training, ADA [40], and hole-based pseudo-labelling. We measure the
mean DSC and average symmetric surface distance (ASSD). For non hetero-modality
variants, we use majority voting across each single-phase prediction to produce a multi-
phase output. We also test against the publicly available hybrid H-DenseUNet model [25],
one of the best published models. It uses a cascade of 2D and 3D networks.
As Table 5 indicates, despite being only a single 2D network, our PHNN baseline
is strong, comparing similarly to the cascaded 2D/3D H-DenseUNet on our dataset5.
However, both H-DenseUNet and our PHNN baseline still struggle to perform well
Table 1. Pathological Liver Segmentation. Mean DSC and ASSD results on the Anonymized
PACS dataset are tabulated across different contrast phase inputs. For “All”, all available phases
in the CT study are used as input. Number of samples are indicated in parentheses.
Models
NC (96) A (98) V (97) D (98) All (100)
DSC ASSD DSC ASSD DSC ASSD DSC ASSD DSC ASSD
HDenseUNet [25] 85.2 3.25 90.1 2.19 90.7 2.61 85.2 2.91 89.9 2.59
Baseline [14] 84.6 2.97 90.3 1.23 90.7 1.18 86.7 2.12 91.4 1.21
Baseline w pseudo 89.4 1.97 90.5 1.34 90.9 1.29 90.6 2.03 91.9 1.27
Baseline w ADA [40] 90.9 1.34 91.9 1.13 91.5 1.14 90.9 1.65 92.6 1.03
Co-training [31] 92.8 0.95 93.4 0.84 93.4 0.83 92.4 0.99 94.0 0.92
Co-hetero 93.4 0.81 93.7 0.77 94.5 0.79 93.6 0.86 94.7 0.89
Co-hetero w ADA 93.8 0.81 93.9 0.79 94.8 0.66 93.9 0.81 95.0 0.68
CHASe 94.0 0.79 94.2 0.74 94.9 0.66 94.1 0.80 95.4 0.63
on the Anonymized dataset, particularly on non V -phases, indicating that training on
public data alone is not sufficient. In contrast, through its principled semi-supervised
approach, CHASe is able to dramatically increase performance, producing boosts of
9.4%, 3.9%, 4.2%, 7.4%, and 4.0% in mean DSCs for inputs of NC, A, V, D, and all
phases, respectively. As can also be seen, all components contribute to these improve-
ments, indicating the importance of each to the final result. Compared to established
baselines of co-training and ADA, CHASe garners marked improvements. In addition,
CHASe performs more strongly as more phases are available, something the baseline
models are not always able to do. Results across all 15 possible combinations, found in
our supplementary material, also demonstrate this trend.
While these mean-valued metrics are persuasive, even more compelling results can
be found in Figure 5’s box and whisker plots. As can be seen, each component is not
only able to reduce variability, but more importantly significantly improve worst-case
results. These same trends are seen across all possible phase combinations. Compared to
improvements in mean DSCs, these worst-case reductions, with commensurate boosts
in reliability, can often be more impactful for clinical applications. Unlike CHASe, most
prior work on pathological liver segmentation is fully-supervised [2,13,36,25,20,43,46].
For instance, Wang et al. report 96.4% DSC on 26 LiTS volumes and Yang et al. [46]
report 95% DSC on 50 test volumes with unclear healthy vs pathological status. As
5 A caveat is that the public H-DenseUNet model was only trained on the LiTS subset of D`.
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Fig. 5. Box and whisker plot. Shown is the distribution of DSCs of pathological liver segmenta-
tion on the Anonymized PACS when using all available phases for inference.
Table 5 demonstrates, fully-supervised baselines may struggle when faced with new
data. Our philosophy is different: we aim to match state-of-the-art performance with-
out relying on fully-supervised labels. We achieve comparable, or better, DSCs on 100
pathological multi-phase test studies. As such, we articulate a versatile strategy to use
and learn from the vast amounts of uncurated multi-phase clinical data housed within
hospitals.
These quantitative results are supported by qualitative examples in Figure 8. Of
note, CHASe is able to provide tangible improvements in consistency and reliability,
robustly predicting even when presented with image features not seen in D`. More
qualitative examples can be found in our supplementary material.
4.2 Liver and Lesion Segmentation
We also present an ablation study on our D` test set of 47 single-phase V volumes,
measuring DSC scores of the liver and lesions. Here, we investigate whether using
CHASe on unlabelled data can boost performance on the labelled data. Note, we do not
include results from the public H-DenseUNet [25] implementation, as it included some
of our test instances originating from LiTS in its training set. From Tab. 5, the empirical
quantitative segmentation performances of [25] and [14] are similar.
Table 2. Ablation study on public data. Presented are test set DSC scores of healthy liver,
lesion, and liver region.
Model Liver Lesion Liver region
Baseline [14] 96.3 47.5 96.6
Co-training 96.3 51.9 96.7
Co-hetero 96.4 53.2 96.7
Co-hetero w ADA 96.5 61.0 97.0
CHASe 96.8 60.3 97.1
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Fig. 6. Qualitative results. As the first two rows demonstrate, H-DenseUNet [25] and our
baseline can perform inconsistently across contrast phases, with both being confused by the
splenomegaly (overly large spleen) of the patient. The CHASe components are able to cor-
rect these issues. The third row depicts an example of a TACE-treated lesion, not seen in the
public dataset and demonstrates how CHASe’s components can progressively correct the under-
segmentation. Finally, the last row depicts the worst-case performance of CHASe. Despite this
unfavorable selection, CHASe is still able to predict better masks than the alternatives. Green
and red curves depict the ground truth and segmentation predictions, respectively.
As Table 2 indicates, each CHASe component can boost scores on data coming from
the labeled domain. In particular, lesion scores are dramatically boosted after training
on unlabelled data. Direct comparisons against other lesion segmentation works, all
typically using the LiTS challenge, are not possible, given the differences in evaluation
data. We do note that 57% of the patients in our test set are healthy, compared to the 3%
in LiTS. Including more healthy cases will tend to make it a harder lesion evaulation
set, as any amount of false positives set DSC scores to zero. Even so, nnUNet [20],
the winner of the Medical Decathlon, reported similar results on LiTS, with 61% and
74% DSCs for their own validation split and the challenge test set, respectively. Lesion
segmentation works typically involve cascaded 2D and 3D networks [20,25] and/or
complex enhancements to standard backbones [25,44]. In contrast, CHASe allows a
standard backbone, with no bells or whistles, to achieve dramatic boosts in lesion seg-
mentation performance. Our supplementary includes box and whisker plots. As such,
these results broaden the applicability of CHASe, suggesting it can even improve the
intra-domain performance of fully-supervised models, such as those cited above.
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5 Conclusion
We presented CHASe, a powerful semi-supervised approach to organ segmentation.
Clinical datasets often comprise multi-phase data and image features not represented
in single-phase public datasets. Designed to manage this challenging domain shift,
CHASe can adapt publicly trained models to robustly segment multi-phase clinical
datasets with no extra annotation. To do this, we integrate co-training and hetero-
modality into a co-heterogeneous training framework. Additionally, we propose a highly
computationally efficient ADA for multi-view setups and a principled holes-based pseudo-
labeling. To validate our approach, we apply CHASe to a highly challenging dataset
of 1147 multi-phase dynamic contrast CT volumes of patients, all with liver lesions.
Compared to strong fully-supervised baselines, CHASe dramatically boosts mean per-
formance (> 9% in NC DSCs), while also drastically improving worse-case scores.
Future work should incorporate other backbones and apply this approach to other med-
ical organs. Even so, these results indicate that CHASe provides a powerful means to
adapt publicly-trained models to challenging clinical datasets found “in-the-wild”.
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Supplementary material
Implementation details
We first initialize CHASe with the weights trained on supervised venous phase data
from the public datasets. To train this segmentation network, we use the Adam opti-
mizer [51] with an initial learning rate of 3 × 10−4 and values of 0.9 and 0.99 for the
β1 and β2 hyperparamters, respectively. We reduce learning rates when the validation
accuracy does not improve for 10 epochs using a factor of 0.1.
To train CHASe, we use the stochastic gradient descent (SGD) optimizer with an
initial learning rate of 1 × 10−5 and a momentum of 0.9. We reduce the learning rate
when the validation loss does not reduce for 10 epochs using a factor of 0.1.
For training the discriminator, we use the Adam optimizer with an initial learning
rate of 3× 10−4 and reduce the learning rate with a polynomial decay schedule with a
power of 0.9 as specified in [40].
We augment the dataset in both source and target domain by performing random
rotation, random elastic deformation, gamma correction and random scaling.
Additional Results
Table 4 shows the performance of different models on the test dataset using all 15 possi-
ble combinations of phases during inference. For H-DenseUNet, Baseline, Co-training,
which do not naturally accept multi-channel inputs, we perform majority voting across
the appropriate single-phase predictions.
Table 3. Data distribution for D`. Each dataset shows whether it contains only healthy liver or
pathological liver and the number of volumes.
Dataset (D`) Total Healthy Pathological
liver
LiTS 130 3
CHAOS 40 3
3D-IRCADb 20 3
Gibson 35 3
Sliver07 20 3
Table 5 provides the ablation study results when VGG16 is used as backbone.
As can be seen, the results exhibit identical trends as when using a ResNet50-based
DeepLabv2 backbone, except that absolute numbers are slightly worse. Nonetheless,
even with an older backbone CHASe is able to provide excellent results.
Figure 7 depicts a box-and-whisker plot of the lesion DSC scores on the public
dataset. As can be seen, all components of CHASe contribute to higher performance.
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Table 4. Combination of views. Mean DSCs are tabulated across different combinations of con-
trast phases used for input. The number of samples are indicated in parentheses. 3 signifies the
presence of a phase and 6 represents the absence of a phase.
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6 6 6 3 85.7 86.4 92.9 93.8 94.0 94.3
6 6 3 6 90.9 90.7 93.7 94.5 94.9 95.0
6 6 3 3 90.5 90.9 93.8 94.7 94.9 94.8
6 3 6 6 90.8 91.1 93.6 94.1 94.3 94.6
6 3 6 3 91.1 91.3 93.1 94.6 94.9 95.1
6 3 3 6 91.9 91.8 92.9 94.8 94.8 95.0
6 3 3 3 91.4 91.6 93.5 95.0 95.2 95.2
3 6 6 6 85.6 85.9 92.4 93.5 93.8 94.0
3 6 6 3 90.4 90.7 92.6 93.8 94.0 94.1
3 6 3 6 91.1 91.8 93.4 94.9 95.1 95.2
3 6 3 3 91.2 92.0 94.1 94.8 95.0 95.4
3 3 6 6 90.9 91.6 93.7 94.9 94.8 95.0
3 3 6 3 91.6 91.4 94.3 95.0 95.0 95.2
3 3 3 6 91.5 91.9 94.4 95.0 95.1 95.3
3 3 3 3 91.6 92.1 94.5 95.1 95.4 95.7
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Table 5. Pathological Liver Segmentation. Mean DSC and ASSD results on the Anonymized
PACS dataset are tabulated across different contrast phase inputs. For “All”, all available phases in
the CT study are used as input. Number of samples are indicated in parentheses. The segmentation
model is trained with VGG16 backbone.
Models
NC (96) A (98) V (97) D (98) All (100)
DSC ASSD DSC ASSD DSC ASSD DSC ASSD DSC ASSD
HDenseUNet 85.2 3.25 90.1 2.19 90.7 2.61 85.2 2.91 89.9 2.59
Baseline 85.1 2.81 90.1 1.33 90.2 1.21 86.9 2.03 90.9 1.25
Baseline w pseudo 87.4 1.47 90.3 1.37 90.8 1.13 91.1 1.12 91.7 1.23
Baseline w ADA 88.3 1.38 91.2 1.08 91.1 1.12 92.1 0.99 92.4 1.01
Co-training 91.8 1.03 92.5 1.01 92.9 0.95 92.5 1.02 93.8 0.99
Co-hetero 93.1 0.95 93.3 0.95 94.0 0.80 93.1 1.06 94.6 0.73
Co-hetero w ADA 93.4 0.89 93.6 0.85 94.3 0.74 93.6 0.91 94.7 0.73
CHASe 93.7 0.82 93.8 0.83 94.2 0.73 93.8 0.87 95.0 0.70
Fig. 7. Box-and-whisker plots of lesion scores on the public dataset. DSCs of 1.0 and near 0.0
are possible, as many studies had no lesions present. If the model did not predict any lesions,
it yielded perfect DSCs. Conversely, predictions of any lesion when none are present penalize
scores very heavily.
Although the mean scores of CHASe were lower when using the holes-based pseudo-
labeling (see main text), the figure demonstrates that the median values are higher, with
a tighter spread of quartile values.
Figure 8 depicts additional qualitative results demonstrating the visual improve-
ments provided by CHASe.
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Fig. 8. Qualitative results. Green and red curves depict the ground truth and segmentation pre-
dictions, respectively. All predictions executed with all phases used as input. The first and last
rows depict failure cases, where the latter is an extremely challenging case with an extraordi-
narily large lesion occupying much of the liver space. CHASe still manages to provide superior
results compared to the alternatives. The second row demonstrates CHASe’s ability to account
for TACE-treated lesions, which are not present in public datasets. The fourth row depicts another
highly challenging case, where the gallbladder is difficult to distinguish from a lesion. As can be
seen, CHASe is the only model able to successfully differentiate these two structures.
